USP42 rs3764814: Extreme Longevity and Gene Expression
rs3764814 is a single nucleotide polymorphism located in the USP42 gene on chromosome 7. Genome-wide association research has identified this variant as an expression quantitative trait locus (eQTL) associated with extreme human longevity and reduced risk of age-related cardiovascular conditions. Carrying the minor C allele has been shown to be enriched among individuals who survive to centenarian ages.
What each genotype means
Baseline longevity association
This genotype represents the common variant at the USP42 locus. Research has identified this region as an expression quantitative trait locus (eQTL) associated with extreme longevity, though the specific biological mechanisms remain an area of ongoing study.
Carried by the majority of individuals of European ancestry, as the minor allele frequency for this variant is approximately 0.08 to 0.12.
Baseline longevity association
This genotype represents a heterozygous state at the USP42 locus. While this variant is linked to longevity research, it is important to note that genetic associations with lifespan are complex and influenced by many environmental and lifestyle factors.
Carried by roughly 1 in 5 to 1 in 6 people of European ancestry.
Potential longevity-associated profile
This genotype contains the minor allele at the USP42 locus, which has been identified in studies as a potential marker for extreme longevity. As this is a statistical association, it does not guarantee specific health outcomes and should be viewed as one small piece of a much larger genetic puzzle.
Carried by approximately 1 in 100 people of European ancestry, based on a minor allele frequency of 0.08 to 0.12.
Genomic Context and the rs3764814 Variant
The single nucleotide polymorphism rs3764814 resides on chromosome 7 within the coding sequence of the USP42 gene, specifically located in its 12th exon. At the molecular sequence level, it represents a synonymous base substitution—traditionally characterized by the major T allele and the minor C allele—which means it does not alter the encoded amino acid sequence of the resulting protein. Because synonymous variants do not alter protein structure directly, researchers look at regulatory mechanisms to understand their physiological relevance. According to functional genomic profiling including the Genotype-Tissue Expression (GTEx) project, rs3764814 acts as an expression quantitative trait locus (eQTL), modulating the transcript levels of USP42 across multiple human tissues. This indicates that while the variant does not alter the protein sequence, it may influence cellular biology by altering the rate or efficiency of USP42 expression.
Biological Role of the USP42 Gene
The USP42 gene encodes ubiquitin-specific peptidase 42, an enzyme belonging to the deubiquitinating enzyme (DUB) family. Deubiquitinases are critical components of the ubiquitin-proteasome system, a cellular quality-control pathway that regulates protein degradation, recycling, and post-translational modifications. By selectively removing ubiquitin tags from target proteins, USP42 protects these substrates from proteasomal destruction, thereby regulating protein stability and turnover. Notably, research highlights that USP42 participates in transcriptional regulation and cellular stress response pathways, such as interacting with and stabilizing the tumor suppressor p53 during cellular stress. Cellular homeostasis, efficient protein recycling, and robust DNA damage responses are widely considered cornerstones of healthy aging. By participating in cellular maintenance pathways, changes in USP42 expression mediated by regulatory variants could plausibly impact long-term cellular survival and resilience against accumulated physiological damage.
Evidence Linking rs3764814 to Longevity and Healthspan
The primary clinical and epidemiological interest in rs3764814 stems from large-scale studies exploring the genetics of extreme human lifespan. In a multi-cohort genome-wide association study incorporating datasets such as the New England Centenarian Study (NECS) and the Long Life Family Study (LLFS), the C allele was identified as a longevity-associated variant. Researchers observed that the prevalence of the C allele increased substantially among centenarians compared to younger control cohorts. Furthermore, analysis of age-of-onset records revealed that individuals carrying the longevity allele exhibited significantly reduced risks of developing cardiovascular disease and hypertension. However, the evidence remains classified as moderate: the association was predominantly observable in individuals who achieved exceptionally old ages (such as centenarians) and showed statistical heterogeneity when evaluated in cohorts of less extreme survival. Additional prospective cohorts across diverse ancestries are required to fully elucidate its role.
Population Frequency and Ancestral Distribution
Allele frequencies for rs3764814 show that the longevity-associated C allele is the minor allele across general human populations. In cohorts of European ancestry, the minor allele frequency (MAF) consistently ranges between approximately 0.07 and 0.12, meaning that the overwhelming majority of people carry the TT genotype. Heterozygous individuals carrying the TC genotype make up a smaller portion of the population (roughly 14% to 20%), while individuals homozygous for the longevity allele (CC) are relatively rare, representing roughly 1% of individuals in standard reference datasets. Because the statistical association with exceptional lifespan was primarily mapped in European-derived cohorts, more research is needed to determine the frequency, linkage patterns, and phenotypic correlations of rs3764814 among African, East Asian, South Asian, and admixed populations.
Interpreting Your Genetic Results
Discovering your rs3764814 genotype can offer interesting educational insights into genetic variations linked to aging, but it is not a diagnostic test or an absolute predictor of your lifespan. Extreme human longevity is a complex, multifactorial trait influenced by hundreds of small-effect genetic variants alongside environment, nutrition, physical activity, and access to medical care. Carrying the longevity-associated C allele does not guarantee extreme age or complete immunity from cardiovascular conditions, nor does possessing the common TT genotype preclude living a long, vibrant life. Genetic markers for longevity merely describe subtle statistical variations observed in population studies. Consumers should avoid modifying their healthcare routines or medications based on single-SNP results and should instead rely on established preventive health practices—such as routine checkups, balanced nutrition, and blood pressure management—under the supervision of a physician.
How common is this variant?
The minor C allele exhibits a frequency of approximately 8% to 12% in European populations, making the homozygous TT genotype the most common, while the CC genotype is present in only 1% to 2% of individuals.
Frequently asked questions
What does having the rs3764814 C allele mean for my lifespan?
Carrying the C allele means you possess a genetic variant that was found at higher rates among centenarians in longevity studies. However, genetics represents only one component of aging, and carrying this variant does not guarantee that you will live to an extreme age.
Does rs3764814 alter the protein structure of USP42?
No, rs3764814 is a synonymous single nucleotide polymorphism located in exon 12 of the USP42 gene, meaning it does not change the amino acid sequence of the protein. Instead, it appears to act as an expression quantitative trait locus (eQTL) that influences how much of the USP42 transcript is expressed in tissues.
Can rs3764814 be used to diagnose or predict cardiovascular disease?
No, this genetic variant cannot be used to diagnose or reliably predict whether you will develop cardiovascular disease. While researchers noted reduced statistical risks of hypertension and heart disease in carriers of the C allele, overall cardiovascular risk depends heavily on standard clinical metrics like blood pressure, cholesterol, and daily habits.
Is the CC genotype common in the general population?
No, the CC genotype is relatively rare, appearing in roughly 1% to 2% of people of European descent. The vast majority of individuals carry the TT genotype, while a smaller fraction carries the heterozygous TC genotype.
Sources & further reading
Educational information only, last refreshed 9/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3764814?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29